Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/18/2865285/8790/en/TG-Therapeutics-Announces-Additional-Data-Presentations-for-BRIUMVI-ublituximab-xiiy-in-Multiple-Sclerosis-at-the-American-Academy-of-Neurology-2024-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/04/18/2865236/8790/en/TG-Therapeutics-Awarded-National-Contract-by-the-Department-of-Veterans-Affairs-for-BRIUMVI-as-the-Preferred-Anti-CD20-for-Relapsing-Forms-of-Multiple-Sclerosis.html
https://www.globenewswire.com/news-release/2024/04/15/2862657/8790/en/TG-Therapeutics-Announces-Presentation-of-Data-for-BRIUMVI-ublituximab-xiiy-in-Multiple-Sclerosis-at-the-American-Academy-of-Neurology-2024-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/03/08/2843057/8790/en/TG-Therapeutics-Announces-Schedule-of-Data-Presentations-for-BRIUMVI-ublituximab-in-Multiple-Sclerosis-at-the-American-Academy-of-Neurology-2024-Annual-Meeting.html
https://www.globenewswire.com//news-release/2024/03/01/2838758/8790/en/TG-Therapeutics-Announces-Presentation-of-Data-for-BRIUMVI-in-Multiple-Sclerosis-at-the-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis-Annual-Forum.html
https://www.globenewswire.com//news-release/2024/02/28/2836785/8790/en/TG-Therapeutics-Provides-Business-Update-and-Reports-Fourth-Quarter-and-Year-End-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/27/2835897/8790/en/TG-Therapeutics-Announces-Issuance-of-Additional-Patents-for-BRIUMVI-ublituximab-xiiy.html
https://www.globenewswire.com//news-release/2024/02/26/2835010/8790/en/TG-Therapeutics-Announces-European-Launch-of-BRIUMVI-ublituximab-xiiy.html
https://www.globenewswire.com//news-release/2024/02/23/2834408/8790/en/TG-Therapeutics-to-Host-Conference-Call-on-Fourth-Quarter-and-Year-End-2023-Financial-Results-and-Business-Update.html
https://www.globenewswire.com//news-release/2024/02/20/2831720/8790/en/TG-Therapeutics-Announces-Schedule-of-Data-Presentations-for-BRIUMVI-ublituximab-in-Multiple-Sclerosis-at-the-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis-An.html